| | | | | |
| $31,7150 | -0,14% | $280,50M | $101,00 | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | $14,0900 | +0,00% | $280,16M | $33,46K | |
TSI TCW Strategic Income Fund, Inc. | $4,3600 | +0,00% | $279,70M | $324,88K | |
PAII Pyrophyte Acquisition Corp. II | $10,2800 | +0,20% | $279,21M | $7,000 | |
| $14,6200 | -0,07% | $279,07M | $1,29K | |
YDES YD Bio Limited Ordinary Shares | $4,9100 | +4,69% | $279,07M | $39,00 | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | $9,9890 | -0,01% | $278,71M | $30,00 | |
RWAY Runway Growth Finance Corp. Common Stock | $6,6350 | -0,08% | $278,70M | $2,05K | |
JILL J.Jill, Inc. Common Stock | $20,2100 | +0,00% | $278,69M | $46,87K | |
LCTX Lineage Cell Therapeutics, Inc. | $1,0898 | +0,91% | $278,19M | $367,00 | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | $10,3150 | +0,05% | $278,12M | $7,000 | |
ACV Virtus Diversified Income & Convertible Fund | $26,3300 | -1,20% | $278,09M | $20,60K | |
ALXO ALX Oncology Holdings Inc. Common Stock | $2,0350 | -0,25% | $277,93M | $9,000 | |
| $1,4200 | -0,70% | $277,83M | $67,00 | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | $3,0900 | +3,00% | $277,66M | $5,000 | |
